205470 — Humasis Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Market Cap
KR₩154bn
Enterprise Value
-KR₩6bn
Revenue
KR₩25bn

Annual income statement for Humasis Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	45,717	321,829	471,273	13,827	25,413
Cost of Revenue
Gross Profit	30,861	210,393	255,902	-36,942	1,131
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	20,359	128,236	261,947	74,422	71,277
Operating Profit	25,358	193,593	209,325	-60,595	-45,864
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	20,962	196,727	237,557	-62,180	-37,628
Provision for Income Taxes
Net Income After Taxes	20,937	151,205	182,627	-55,424	-35,610
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	20,937	151,205	182,627	-55,424	-30,442
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	20,937	151,205	182,627	-55,424	-30,442
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	161	1,106	1,428	-314	-64.5
Dividends per Share